NSETrading Window22 Jun 2026 · 22 Jun 2026, 10:53 am

Trading Window

IPCA Laboratories Limited · IPCALAB

✦ AI Summary

IPCA Laboratories Limited announced the closure of its trading window for insiders, effective from July 1, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and will remain in effect until 48 hours after the declaration of the unaudited financial results for the first quarter ended June 30, 2026. The date of the Board meeting for considering these results will be intimated later.

Analysis Scores

Earnings Impact5/10

Growth Catalyst1/10

Governance Concern1/10

Regulatory Risk1/10

Balance Sheet Risk5/10

Liquidity Impact5/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

IPCA Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

IPCALAB_22062026105312_IpcaClosureofTradingWindow.pdf

pdf

Download →

View document text

THRU ONLINE FILING June 22, 2026 BSE Ltd. National Stock Exchange India Limited, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block-G, Dalal Street Bandra Kurla Complex, Bandra – (East). Mumbai 400 023 Mumbai-400051. Scrip Code : 524494 Scrip Code : IPCALAB Sub: Closure of trading window Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby notified that the trading window for dealing in the securities of the Company by the insiders as defined under the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed with effect from 1st July, 2026 and until 48 hours after the declaration of the Company’s unaudited financial results for the 1st quarter ended 30th June, 2026 of the financial year 2026-27. The date of the Board meeting for consideration of the said unaudited financial results would be intimated to the stock exchanges in due course of time. Thanking you Yours faithfully For Ipca Laboratories Limited Harish Kamath Corporate Counsel & Company Secretary ACS 6792